1st AI-enabled radiation reduction solution for X-rays cleared by FDA

Omega Medical Imaging’s FluoroShield gained FDA clearance this month, becoming the first AI-enabled radiation reduction technology to hit the market.

According to Omega, the FluoroShield—a region of interest radiation exposure reduction solution for interventional X-ray imaging—is powered by a combination of AI, an ultrafast collimator and advanced image processing. In testing, it’s reduced radiation by as much as 84%.

The approach minimizes radiation doses to both patients and nearby staff, and Omega’s site states it “seamlessly helps you reach your ALARA (as low as reasonably achievable) goals.”

Right now, FluoroShield is only compatible with Omega’s Flat Panel detector CS-series product lines.

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.